CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

SMMT Inks Deal With AZN-Daiichi to Study Ivonescimab + Datroway Combos

PartnershipIvonescimabDatrowayPositive
AI Analysis

Summary

SMMT has entered into a deal with AstraZeneca and Daiichi Sankyo to study combination therapies of Ivonescimab and Datroway. The partnership aims to evaluate the efficacy of these drug combinations in clinical research.

Importance:6/10
Sentiment:
0.50
partnershipcombination_studycollaboration
Related Companies

Read the original article

Published by yahoo_finance on October 5, 2026 1:37 PM

Read Original